➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Litigation Details for Bayer Healthcare Pharmaceuticals, Inc. v. River's Edge Pharmaceuticals, LLC (N.D. Ga. 2011)

Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Bayer Healthcare Pharmaceuticals, Inc. v. River's Edge Pharmaceuticals, LLC
The small molecule drugs covered by the patent cited in this case are ⤷  Free Forever Trial , ⤷  Free Forever Trial , and ⤷  Free Forever Trial .

Details for Bayer Healthcare Pharmaceuticals, Inc. v. River's Edge Pharmaceuticals, LLC (N.D. Ga. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-05-19 1 Complaint States Patent No. 6,387,383 entitled “TOPICAL LOW-VISCOSITY GEL COMPOSITION” (“the ’383 patent”), including…the ’383 patent from Dow, with the right to enforce the ’383 patent. A copy of the ’383 patent is attached…. This is an action for patent infringement arising under the patent laws of the United States, Title…act of infringement of the ’383 patent under the United States Patent Law, 35 U.S.C. § 271(e)(2)(A). …07962. Intendis is an exclusive licensee of the patent in suit identified in paragraph 11 below and is External link to document
2012-11-08 121 and experience; my review of U.S. Patent No. 6,387,383 (“the ’383 patent”) (Lucia Ex. 1)1 and its prosecution…Page 6 of 21 III. THE ’383 PATENT 16. The ’383 patent, entitled “Topical Low-Viscosity …specification of the ’383 patent, the prosecution history of the ’383 patent, and the additional information…the foundational patent that established this class of materials, i.e., U.S. Patent No. 2,798,053 (“…(“the ’053 patent) (Lucia Ex. 2). The ’053 patent is assigned to The B.F. Goodrich Company, which introduced External link to document
2012-11-08 122 Markman Brief Proposed Claim Construction for United States Patent No. 6,387,383 filed by River's Edge Pharmaceuticals, LLC… 15 November 2018 1:11-cv-01634 830 Patent Defendant District Court, N.D. Georgia External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.